Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT

Journal of Molecular Biology

Volumn 413, Issue 4, 2011, Pages 762-772

  Kojima, Rieko ^a,b   Kajikawa, Mizuho ^b   Shiroishi, Mitsunori ^b   Kuroki, Kimiko ^a,b   Maenaka, Katsumi ^a,b,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

CD160; cosignaling molecules; HVEM; T cell regulation

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR; CD160 PROTEIN; CL1 R2; HERPESVIRUS ENTRY MEDIATOR; LYMPHOCYTE RECEPTOR; LYMPHOTOXIN; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOREGULATION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; VIRUS ENTRY;

HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 80054846953     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.09.018     Document Type: Article

References (37)

1. Arase, H. & Lanier, L. L. (2004). Specific recognition of virus-infected cells by paired NK receptors. Rev. Med. Virol. 14, 83-93. (Pubitemid 38316008)
2. Bretscher, P. A. (1999). A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl Acad. Sci. USA, 96, 185-190.
3. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. & Nadler, L. M. (1993). Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl Acad. Sci. USA, 90, 6586-6590. (Pubitemid 23207258)
4. Freeman, G. J., Wherry, E. J., Ahmed, R. & Sharpe, A. H. (2006). Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203, 2223-2227. (Pubitemid 44498355)
5. Greenwald, R. J., Freeman, G. J. & Sharpe, A. H. (2005). The B7 family revisited. Annu. Rev. Immunol. 23, 515-548. (Pubitemid 40563179)
6. Cai, G. & Freeman, G. J. (2009). The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229, 244-258.
7. Cai, G., Anumanthan, A., Brown, J. A., Greenfield, E. A., Zhu, B. & Freeman, G. J. (2008). CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9, 176-185.
8. Agrawal, S., Marquet, J., Freeman, G. J., Tawab, A., Bouteiller, P. L., Roth, P. et al. (1999). Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J. Immunol. 162, 1223-1226. (Pubitemid 29306988)
9. Barakonyi, A., Rabot, M., Marie-Cardine, A., Aguerre-Girr, M., Polgar, B., Schiavon, V. et al. (2004). Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J. Immunol. 173, 5349-5354. (Pubitemid 39392117)
10. Le Bouteiller, P., Barakonyi, A., Giustiniani, J., Lenfant, F., Marie-Cardine, A., Aguerre-Girr, M. et al. (2002). Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl Acad. Sci. USA, 99, 16963-16968. (Pubitemid 36034081)
11. Li, Q., Smith, A. J., Schacker, T. W., Carlis, J. V., Duan, L., Reilly, C. S. & Haase, A. T. (2009). Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J. Immunol. 183, 1975-1982.
12. Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A. et al. (2009). Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29-37.
13. Stiles, K. M., Whitbeck, J. C., Lou, H., Cohen, G. H., Eisenberg, R. J. & Krummenacher, C. (2010). Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition. J. Virol. 84, 11646-11660.
14. Harrop, J. A., McDonnell, P. C., Brigham-Burke, M., Lyn, S. D., Minton, J., Tan, K. B. et al. (1998). Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 273, 27548-27556. (Pubitemid 28500476)
15. Steinberg, M. W., Shui, J. W., Ware, C. F. &Kronenberg, M. (2009). Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners. Semin. Immunopathol. 31, 207-221.
16. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhai, Y., Su, J., Chen, S. F. et al. (2000). LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164, 4105-4110. (Pubitemid 30215066)
17. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhu, G., Sica, G., Flies, D. et al. (2000). Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 6, 283-289. (Pubitemid 30148620)
18. Yu, P., Lee, Y., Liu, W., Chin, R. K., Wang, J., Wang, Y. et al. (2004). Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5, 141-149. (Pubitemid 38208355)
19. Granger, S. W. & Rickert, S. (2003). LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev. 14, 289-296. (Pubitemid 36693148)
20. Harrop, J. A., Reddy, M., Dede, K., Brigham-Burke, M., Lyn, S., Tan, K. B. et al. (1998). Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol. 161, 1786-1794. (Pubitemid 28387598)
21. Shaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M. et al. (2001). Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J. Immunol. 167, 6330-6337. (Pubitemid 33081564)
22. Wang, Y., Subudhi, S. K., Anders, R. A., Lo, J., Sun, Y., Blink, S. et al. (2005). The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Invest. 115, 711-7117.
23. Compaan, D. M., Gonzalez, L. C., Tom, I., Loyet, K. M., Eaton, D. & Hymowitz, S. G. (2005). Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J. Biol. Chem. 280, 39553-39561. (Pubitemid 41713914)
24. Han, P., Goularte, O. D., Rufner, K., Wilkinson, B. &Kaye, J. (2004). An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172, 5931-5939. (Pubitemid 38621192)
25. Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K. et al. (2003). BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4, 670-679. (Pubitemid 36874444)
26. Deppong, C., Juehne, T. I., Hurchla, M., Friend, L. D., Shah, D. D., Rose, C. M. et al. (2006). Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J. Immunol. 176, 3909-3913. (Pubitemid 44264367)
27. Anumanthan, A., Bensussan, A., Boumsell, L., Christ, A. D., Blumberg, R. S., Voss, S. D. et al. (1998). Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161, 2780-2790. (Pubitemid 28425697)
28. Chabot, S., Jabrane-Ferrat, N., Bigot, K., Tabiasco, J., Provost, A., Golzio, M. et al. (2011). A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J. Exp. Med. 208, 973-986.
29. Maiza, H., Leca, G., Mansur, I. G., Schiavon, V., Boumsell, L. & Bensussan, A. (1993). A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J. Exp. Med. 178, 1121-1126. (Pubitemid 23260453)
30. Carfi, A., Willis, S. H., Whitbeck, J. C., Krummenacher, C., Cohen, G. H., Eisenberg, R. J. & Wiley, D. C. (2001). Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell, 8, 169-179. (Pubitemid 32772915)
31. Nelson, C. A., Fremont, M. D., Sedy, J. R., Norris, P. S., Ware, C. F., Murphy, K. M. & Fremont, D. H. (2008). Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator. J. Immunol. 180, 940-947.
32. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M. et al. (2003). Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl Acad. Sci. USA, 100, 8856-8861. (Pubitemid 36899188)
33. Cheung, T. C., Steinberg, M. W., Oborne, L. M., Macauley, M. G., Fukuyama, S., Sanjo, H. et al. (2009). Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc. Natl Acad. Sci. USA, 106, 6244-6249.
34. Sarrias, M. R., Whitbeck, J. C., Rooney, I., Ware, C. F., Eisenberg, R. J., Cohen, G. H. & Lambris, J. D. (2000). The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA. Mol. Immunol. 37, 665-673. (Pubitemid 32112654)
35. Giustiniani, J., Bensussan, A. & Marie-Cardine, A. (2009). Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J. Immunol. 182, 63-71.
36. Aricescu, A. R., Assenberg, R., Bill, R. M., Busso, D., Chang, V. T., Davis, S. J. et al. (2006). Eukaryotic expression: developments for structural proteomics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 62, 1114-1124. (Pubitemid 44526204)
37. Hashiguchi, T., Kajikawa, M., Maita, N., Takeda, M., Kuroki, K., Sasaki, K. et al. (2007). Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc. Natl Acad. Sci. USA, 104, 19535-19540.